Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503854 · ClinicalTrials.gov registry record
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 70
- Enrollment target
NCT00503854: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00503854 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00503854 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
This trial studies how fatigue and symptom burden in low-risk cancer patients undergoing treatment for febrile neutropenia. Cancer and numerous cancer treatments are associated with various symptoms including anemia, fever, and neutropenia, which may also be associated with fatigue. Treating low-risk cancer patients for febrile neutropenia may reduce levels of fatigue.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-05-31 |
| Est. Completion | 2018-04-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00503854
The ClinicalTrials.gov registry entry for NCT00503854 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00503854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00503854 about?
NCT00503854 is a clinical study titled "Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia". This trial studies how fatigue and symptom burden in low-risk cancer patients undergoing treatment for febrile neutropenia. Cancer and numerous cancer treatments are associated with various symptoms including anemia, fever, and neutropenia, which may also be associated with fatigue. Treating low-ris...
What is the current status of trial NCT00503854?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2007-05-31. Estimated completion is 2018-04-05.
What interventions are being tested in trial NCT00503854?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00503854?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.